Epigenetic dysregulation-induced metabolic reprogramming fuels tumor progression in bladder cancer

Abstract excerpt

Background: Bladder cancer remains a significant global health challenge with a high mortality rate despite advancements in treatment modalities. Metabolic alterations serve as crucial contributors to cancer progression, particularly influencing tumor aggressiveness and patient outcomes. Therefore, this study aimed to identify and characterize metabolic hubs associated with disease progression and tumor...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer, Hypoxia, and Metabolism
• Share to Epigenetics and DNA Methylation
• Share to Ferroptosis and cancer prognosis